Dendrimers functionalized with membrane-interacting peptides for viral inhibition

International Journal of Nanomedicine

Volumn 8, Issue , 2013, Pages 521-534

  Tarallo, Rossella ^a   Carberry, Tom P ^b   Falanga, Annarita ^a   Vitiello, Mariateresa ^c   Galdiero, Stefania ^a   Galdiero, Massimiliano ^c   Weck, Marcus ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NEW YORK UNIVERSITY   (United States)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Antiviral activity; Membranotropic peptides; Peptidodendrimer

Indexed keywords

ANTIVIRUS AGENT; GLYCOPROTEIN H[625-644]; PEPTIDODENDRIMER; POLYAMIDE; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELL MEMBRANE; CHEMICAL MODIFICATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG SYNTHESIS; FLOW CYTOMETRY; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HERPES VIRUS; IC 50; NONHUMAN; PROTEIN PROTEIN INTERACTION; SOLID PHASE SYNTHESIS; VERO CELL; VIRUS ENTRY; VIRUS INHIBITION;

ANTIVIRAL ACTIVITY; MEMBRANOTROPIC PEPTIDES; PEPTIDODENDRIMER;

AMINO ACID SEQUENCE; ANIMALS; ANTIVIRAL AGENTS; APOPTOSIS; CERCOPITHECUS AETHIOPS; DENDRIMERS; HERPESVIRUS 1, HUMAN; MOLECULAR SEQUENCE DATA; PEPTIDES; VERO CELLS; VIRAL ENVELOPE PROTEINS; VIRUS INTERNALIZATION;

EID: 84873648748     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S37739     Document Type: Article

References (45)

1. van Benthem BH, Spaargaren J, van Den Hoek JA, Merks J, Coutinho RA, Prins M. Prevalence and risk factors of HSV-1 and HSV-2 antibodies in European HIV infected women. Sex Transm Infect. 2001;77(2): 120-124.
2. Superti F, Ammendolia MG, Marchetti M. New advances in Anti-HSV chemotherapy. Curr Med Chem. 2008;15(9):900-911.
3. Greco A, Diaz JJ, Thouvenot D, Morfin F. Novel targets for the development of anti-herpes compounds. Infect Disord Drug Targets. 2007;7(1): 11-18.
4. Keller MJ, Tuyama A, Carlucci MJ, Herold BC. Topical microbicides for the prevention of genital herpes infection. J Antimicrob Chemother. 2005;55(4):420-423.
5. Lee CC, MacKay JA, Fréchet JMJ, Szoka FC. Designing dendrimers for biological applications. Nat Biotech. 2005;23(12):1517-1526.
6. Esfand R, Tomalia DA. Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications. Drug Discov Today. 2001;6(8):427-436.
7. Sadler K, Tam JP. Peptide dendrimers: applications and synthesis. Rev Mol Biotechnol. 2002;90:195-229.
8. Cloninger MJ. Biological applications of dendrimers. Curr Opin Chem Biol. 2002;6:742-748.
9. Niederhafner P, Šebestík J, Ježek J. Peptide dendrimers. J Peptide Sci. 2005;11:757-788.
10. Tekade RK, Kumar PV, Jain NK. Dendrimers in oncology: an expanding horizon. Chem Rev. 2009;109(1):49-87.
11. Newkome GR, Moorefield CN, Vögtle F. Dendrimers and Dendrons: Concepts, Synthesis, Applications. Weinheim: Wiley-VCH; 2001.
12. Fox ME, Szoka FC, Fréchet JMJ. Soluble polymer carriers of the treatment of cancer: the importance of molecular architecture. Acc Chem Res. 2009;42(8):1141-1151.
13. Kolb HC, Finn MG, Sharpless KB. Click chemistry: diverse chemical function from a few good reactions. Angew Chem Int Ed. 2001; 40(11):2004-2021.
14. Franc G, Kakkar A. Dendrimer design using Cu-catalyzed alkyne-azide "click chemistry". Chem Commun. 2008;44(42):5267-5276.
15. Astruc D, Liang L, Rapakousiou A, Ruiz J. Click dendrimers and triazole-related aspects: catalysts, mechanism, synthesis, and functions. A bridge between dendritic architectures and nanomaterials. Acc Chem Res. 2012;45(4):630-640.
16. Bourne N, Stanberry LR, Kern ER, Holan G, Matthews B, Bernstein DI. Dendrimers, a new class of candidate topical microbicides with activity against herpes simplex virus infection. Antimicrob Agents Chemother. 2000;44(9):2471-2474.
17. Gao H, Louche G, Sumerlin BS, Jahed N, Golas P, Matyjaszewski K. Gradient polymer elution chromatographic analysis of α, ω-dihydroxypolystyrene synthesized via ATRP and click chemistry. Macromolecules. 2005;38(22):8979-8982.
18. Vogt AP, Sumerlin BS. An efficient route to macromonomers via ATRP and click chemistry. Macromolecules. 2006;39(16): 5286-5292.
19. Li H, Cheng F, Duft AM, Adronov A. Functionalization of single-walled carbon nanotubes with well-defined polystyrene by "click" coupling. J Am Chem Soc. 2005;127(41):14518-14524.
20. Luganini A, Nicoletto SF, Pizzuto L, et al. Inhibition of herpes simplex virus type i and type ii infections by peptide-derivatized dendrimers. Antimicrob Agents Chemother. 2011;55(7):3231-3239.
21. Jiang Y-H, Emau P, Cairns JS, et al. SPL7013gel as a topical microbicide for prevention of vaginal transmission of SHIV in macaques. AIDS Res Hum Retrovir. 2005;21(3):207-213.
22. Gong E, Matthews B, McCarthy TD, et al. Evaluation of dendrimer SPL7013, a lead microbicide candidate against herpes simplex viruses. Antivir Res. 2005;68(3):139-146.
23. O'Loughlin J, Millwood I, McDonald HM, Price CF, Kaldor JM, Paull JRA. Safety, tolerability, and pharmacokinetics of SPL7013gel (VivaGel). Sex Transm Dis. 2010;37(2):100-104.
24. Telwatte S, Moore K, Johnson A, et al. Virucidal activity of the dendrimer microbicide SPL7013 against HIV-1. Antivir Res. 2011;90(3): 195-199.
25. Luganini A, Giuliani A, Pirri G, Pizzuto L, Landolfo S, Gribaudo G. Peptide-derivatized dendrimers inhibit human cytomegalovirus infection by blocking virus binding to cell surface heparan sulfate. Antivir Res. 2010;85(3):532-540.
26. Donalisio M, Rusnati M, Civra A, et al. Identification of a dendrimeric heparan sulfate-binding peptide that inhibits infectivity of genital types of human papillomaviruses. Antimicrob Agents Chemother. 2010; 54(10):4290-4299.
27. Hunter AC. Molecular hurdles in polyfectin design and mechanistic background to polycation induced cytotoxicity. Adv Drug Deliv Rev. 2006;58(14):1523-1531.
28. Galdiero S, Falanga A, Vitiello M, et al. Peptides containing membrane-interacting motifs inhibit herpes simplex virus type I infectivity. Peptides. 2008;29:1461-1471.
29. Galdiero S, Falanga A, Vitiello M, et al. Analysis of a membrane interacting region of herpes simplex virus type i glycoprotein H. J Biol Chem. 2008;283(44):29993-30009.
30. Galdiero S, Falanga A, Vitiello M, Browne H, Pedone C, Galdiero M. Fusogenic domains in herpes simplex virus type i glycoprotein H. J Biol Chem. 2005;280(31):28632-28643.
31. Galdiero S, Falanga A, Vitiello M, et al. The presence of a single N-terminal histidine residue enhances the fusogenic properties of a membranotropic peptide derived from herpes simplex virus type I glycoprotein H. J Biol Chem. 2010;285(22):17123-17136.
32. Galdiero S, Falanga A, Vitiello G, et al. Role of membranotropic sequences from herpes simplex virus type i glycoproteins B and H in the fusion process. Biochim Biophys Acta. 2010;1798(3):579-591.
33. Galdiero S, Russo L, Falanga A, et al. Structure and orientation of the gH625-644membrane interacting region of herpes simplex virus type 1in a membrane mimetic system. Biochemistry. 2012;51(14): 3121-3128.
34. Carberry TP, Tarallo R, Falanga A, et al. Dendrimer functionalization with a membrane-interacting domain of herpes simplex virus type 1: towards intracellular delivery. Chem Eur J. 2012;18(43):13678-13685.
35. Mosmann T. Rapid Colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65(1-2):55-63.
36. Vitiello M, Galdiero M. Inhibition of viral-induced membrane fusion by peptides. Protein Pept Lett. 2009;16(7):786-793.
37. Xu Y, Rahman NA, Othman RB, Hu P, Huang M. Computational identification of self-inhibitory peptides from envelope proteins. Proteins. 2012;80(9):2154-2168.
38. Galdiero S, Falanga A, Vitiello M, et al. Evidence for a role of the membrane-proximal region of herpes simplex virus type 1glycoprotein H in membrane fusion and virus inhibition. Chembiochem. 2007;8(8): 885-895.
39. Tarallo R, Accardo A, Falanga A, et al. Clickable functionalization of liposomes with the gH625 peptide from herpes simplex virus type i for intracellular drug delivery. Chem Eur J. 2011;17(45):12659-12668.
40. Falanga A, Vitiello MT, Cantisani M, et al. A peptide derived from herpes simplex virus type 1glycoprotein H: membrane translocation and applications to the delivery of quantum dots. Nanomed Nanotechnol. 2011;7(6):925-934.
41. Galdiero S, Vitiello M, Falanga A, Cantisani M, Incoronato N, Galdiero M. Intracellular delivery: exploiting viral membranotropic peptides. Curr Drug Metab. 2012;13(1):93-104.
42. Newkome GR, Kotta KK, Moorefield CN. Convenient synthesis of 1 → 3 C-branched dendrons. J Org Chem. 2005;70(12):4893-4896.
43. Roberts JC, Bhalgat MK, Zera RT. Preliminary biological evaluation of polyamidoamine (PAMAM) Starburst™ dendrimers. Biomed Mater Res. 1996;30(1):53-65.
44. Majoros IJ, Myc A, Thomas T, Mehta CB, Baker JR Jr. PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality. Biomacromolecules. 2006; 7(2):572-579.
45. Guarnieri D, Falanga A, Muscetti O, et al. Shuttle-mediated nanoparticle delivery to the blood-brain barrier. Small. Epub November 7, 2012. doi: 10.1002/smll.201201870